A report by the Nellore administration didn’t find adverse events, but felt an eye drop could have negative impact. While it was filed on Monday, distribution was stopped only on Friday.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.